Dr Belamy Cheung
Program Manager, Molecular Carcinogenesis
BMed, MSc (Sun Yat-Sen University of Medical Science, Guangzhou), PhD (UNSW)
Dr Belamy Cheung is Manager and Project Leader of the Molecular Carcinogenesis Program at Children's Cancer Institute and a conjoint Senior Lecturer in the UNSW Faculty of Medicine. She was the first to show that the retinoic acid receptor beta acts as a tumour suppressor gene in neuroblastoma and predicts a more favourable outcome for neuroblastoma patients.
Her current research is focusing on drug discovery leading to the identification of small molecule inhibitors of oncogene targets. She plays a key role in directing research in the Molecular Carcinogenesis Program and driving research in MYC oncogenesis, the mechanisms of embryonal cancer initiation, and histone deacetylase inhibitor combination therapy in cancer.
Dr Cheung has been awarded research grants and fellowships from external and internal funding bodies including Cancer Institute NSW, Cure Cancer Australia and UNSW. She was promoted to Project Leader in 2009 and Manager of the Molecular Carcinogenesis Research Program in 2014. Over the past decade, Belamy has authored a number of peer-reviewed publications in well-known scientific journals including Nature Reviews Cancer, Science Translational Medicine, Oncogene and Journal of Pathology.